Zobrazeno 1 - 10 of 15 pro vyhledávání: '"M. Volkava"'
1
AB1113 DIAGNOSTIC VALUE OF ANTI-Sa AND ANTI-hn RNP K ANTIBODIES IN SERONEGATIVE RHEUMATOID ARTHRITIS
Autor: M. Volkava, A. Kundzer
Publikováno v: Annals of the Rheumatic Diseases. 79:1846.1-1846
Background:The diagnostics of seronegative rheumatoid arthritis (RA) remains the important issue in modern rheumatology. Other biomarkers are studied to close the diagnostic gap.Objectives:The aim of work was to assess anti-Sa and anti-hnRNP K in pat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4e456fac6544e3d600488654ea413382
https://doi.org/10.1136/annrheumdis-2020-eular.5407
Zobrazit plný text záznamu
2
AB0658 PREDICTION OF THE EFFECTIVENESS OF TREATMENT WITH INFLIXIMAB BASED ON THE DETERMINATION OF ANTINUCLEAR ANTIBODIES IN PATIENTS WITH ANKYLOSING SPONDYLITIS
Autor: D. Petrovich, M. Volkava, U. Kundzer, Dirk Roggenbuck
Publikováno v: Annals of the Rheumatic Diseases. 79:1624.2-1624
Background:The search for new methods for predicting the effectiveness of treatment for biologics is important issue.Objectives:To study antinuclear antibodies (ANA) levels during of AS treatment by infliximab and evaluate the influence of ANA on tre
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6dcb1e470ae723dbfd77735352abc679
https://doi.org/10.1136/annrheumdis-2020-eular.5363
Zobrazit plný text záznamu
4
AB0368 The occurrence of antibodies depending on the duration of rheumatoid arthritis
Autor: M. Volkava
Publikováno v: Rheumatoid arthritis – comorbidity and clinical aspects.
Background Recently heterogeneous nuclear ribonucleoproteins (hnRNPs) were identified as antigenic targets for autoantibodies in RA. Autoantibodies to RNP B1, B2 and heterogeneous complex A2/b are the most studied and are referred to as ”antigen RA
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3039d137420bf032d5cb7f92581ff994
https://doi.org/10.1136/annrheumdis-2018-eular.6907
Zobrazit plný text záznamu
5
SAT0166 Markers of response to infliximab in rheumatoid arthritis – the place of antinuclear antibody and nuclease serum activity
Autor: A. Kundzer, D. Petrovich, M. Volkava, I. Generalov
Publikováno v: Poster Presentations.
Background It is important to study new potential markers of response to treatment in rheumatoid arthritis (RA), because up to 40% patients don9t achieve remission even using biological therapy. DNAse activity of the blood serum and antinuclear antib
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9a78f6598315375f218bd8e79543db6b
https://doi.org/10.1136/annrheumdis-2017-eular.6941
Zobrazit plný text záznamu
6
Abstracts from EIR School ES01-ES25
Autor: E. Alexeeva, A. Kozlova, S. Valieva, T. Bzarova, A. Chomahizde, K. Isaeva, R. Denisova, T. Slepcova, A. Starkova, V. Amirdzhanova, E. Alexandrova, A. Avdeeva, A. Novikov, E. Panasyuk, M. Cherkasova, N. Klimova, E. Nasonov, A. Aggarwal, A. Sharma, A. Bhatnagar, T. Dubula, G. M. Mody, N. Abdel-Wahab, S. Tayseer Khedr, E. Rashad, E. Alkady, null Mosad, L. Owino, A. Ubeer, Z. Pan, X. Liu, J. Xu, Y. Zhang, N. A. Omurzakova, M. Volkava, A. Kundzer, I. Generalov, W. Tan, H. Wu, J. Zhao, L. A. Derber, D. M. Lee, N. A. Shadick, D. L. Conn, E. A. Smith, V. H. Gersuk, G. T. Nepom, L. W. Moreland, D. E. Furst, S. D. Thompson, B. L. Jonas, V. Michael Holers, D. N. Glass, P. P. Chen, S. Louis Bridges, M. E. Weinblatt, H. E. Paulus, B. P. Tsao, S. Umar, S. Ahmad, C. Kant Katiyar, H. A. Khan, A. Munoz, R. Martinez, S. Rodriguez, J. Luis Marenco, Z. Lu, W. Guo-chun, D. Shah, A. Wanchu, Y. A. Sherif Suliman, A. Budhoo, M. Hristova, Z. Kamenarska, L. Dourmishev, M. Baleva, R. Kaneva, A. Savov, S. Retamozo, C. Diaz-Lagares, P. Brito-Zeron, M.- E. Gomez, X. Bosch, A. Bove, X. Forns, J. Yague, M. Ramos-Casals, Z. Chen, X.-M. Li, G.-S. Wang, L. Qian, X.-P. Li, N. Zu, H. Zhao, B. Xu, H.-y. Li, Q. Xiang, G.-c. Wang, L. Mazur-Nicorici, M. Mazur, L. Crib, H. Ding, S. Chen, S. Ye, E. Fedorenko, G. Lukina, Y. Sigidin, N. Hammam, H. Orabi, T. F. Lue, R. Goel, D. Danda, C. Eapen, J. Mathew, S. Kumar
Publikováno v: Rheumatology. 51:i34-i41
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c3999cab8137a2d8e33b29e9f94c2df9
https://doi.org/10.1093/rheumatology/ker439
Zobrazit plný text záznamu
7
A2.28 Prevalence of antibodies to glycoprotein 2 in patients with spondyloarthropathies
Autor: E Kundzer, M. Volkava, D. Petrovich, I. Generalov
Publikováno v: Annals of the Rheumatic Diseases. 75:A26.2-A27
Background and objectives Autoimmune diseases are characterised by tissue damage and loss of function due to an immune response that is directed against specific organs. Together with the gut-associated lymphoid tissue and the neuroendocrine network,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::07ba0ff69e96d724ca7612ac9682c546
https://doi.org/10.1136/annrheumdis-2016-209124.63
Zobrazit plný text záznamu
8
FRI0015 Anti GP2 Antibody Prevalence in Patients with Rheumatic Diseases
Autor: D. Petrovich, M. Volkava, A. Kundzer, Dirk Roggenbuck, I. Generalov
Publikováno v: Annals of the Rheumatic Diseases. 74:424.1-424
Background Autoimmune diseases are characterized by tissue damage and loss of function due to an immune response that is directed against specific organs. The role of impaired intestinal barrier function on autoimmune pathogenesis is widely discussed
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6699ec39494d16a88767f844fe7827a0
https://doi.org/10.1136/annrheumdis-2015-eular.5677
Zobrazit plný text záznamu
9
AB0126 DNASE Serum and IGG Activity in Patients with Early Arthritis
Autor: M. Volkava, I. Generalov, A. Kundzer
Publikováno v: Annals of the Rheumatic Diseases. 74:932.3-933
Background Early arthritis (EA) is one of the most important problems of modern rheumatology. Searching the new pathogenic mechanism of recently-onset joints inflammation caused by different factors is needed. Enzymatic serum activity is multifactori
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0eb00a15500eed85c9e3dd8eca2ffb59
https://doi.org/10.1136/annrheumdis-2015-eular.5657
Zobrazit plný text záznamu
10
AB0985 Anti-GP2 Antibodies Presense in Patients with Rheumatic Diseases
Autor: A. Kundzer, J. Kobec, I. Generalov, Dirk Roggenbuck, M. Volkava
Publikováno v: Annals of the Rheumatic Diseases. 73:1126.2-1126
Background Autoimmune diseases are characterized by tissue damage and loss of function due to an immune response that is directed against specific organs. The role of impaired intestinal barrier function on autoimmune pathogenesis is widely discussed
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::329aafec98238fe077d416cf44545526
https://doi.org/10.1136/annrheumdis-2014-eular.5545
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje